NUTX
Nutex Health Inc. Common Stock
SERVICES-BUSINESS SERVICES, NEC
Best Business Services Stocks 2026 →
Nutex Health (NUTX) Stock: Buy, Sell, or Hold?
$189.19
+2.94 (+1.58%)
▲
5d:
-7.81%
30d:
-7.42%
90d:
+1.27%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$189.57 – $211.85
Position: OVERSOLD
Forward P/E & Valuation
6.9x
FAIR
vs 7.1x historical avg
Wall Street Target
$296.17
+56.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$170.00 / $215.97
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: NUTX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When NUTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$381.47
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$236.86
20.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NUTX is currently trading at $189.19, which is considered oversold relative to its 30-day fair value range of $189.57 to $211.85. The stock's valuation (Forward PE: 6.9) is in line with its historical norms (7.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NUTX is in a strong uptrend. Immediate support is located at $170.00, while resistance sits at $215.97.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $296.17 (+56.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NUTX is in a strong uptrend. Immediate support is located at $170.00, while resistance sits at $215.97.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $296.17 (+56.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$189.57 -
$211.85
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Trading Range & Key Levels
30-Day Trading Range
$189.57 -
$211.85
Current vs Trading Range
OVERSOLD
Support Level
$170.00
Resistance Level
$215.97
Current Trend
Strong Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 56.5% below Wall St target ($296.17)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
6.86
Wall Street Target
$296.17
(+56.5%)
Revenue Growth (YoY)
-18.7%
Earnings Growth (YoY)
-26.4%
Profit Margin
20.7%
Valuation Discount vs History
-1.0% cheaper
PE vs Historical
6.9 vs 7.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.0%
(market-implied from PE analysis)
1-Year Target
$187.30
(-1%)
2-Year Target
$185.43
(-2%)
3-Year Target
$183.57
(-3%)
3-Yr Target (if PE normalizes)
(PE: 7→7)
$190.07
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 74.5%)
$560.27
(+196%)
Base:
(SPY PE: 6.9, Growth: 74.5%)
$193.45
(+2%)
Bear:
(PE: 5.8, Growth: 74.5%)
$164.43
(-13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (8x PE), but valuation improves significantly next year (7x PE) as earnings recover.
Trailing PE: 8.06 | Current EPS (TTM): $23.11
Bull Case
$244.59
(+29%)
Analyst growth 19.4%, PE expands to 8.9
Base Case
$222.36
(+18%)
Market implied 19.4%, PE stable at 8.1
Bear Case
$126.65
(-33%)
Severe decline -20.0%, PE contracts to 6.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.9 to 7.1
Stabilization Target:
$195.89
(+3.5%)
PE Expansion Potential:
+3.5%
Share NUTX Analysis
Share this live NUTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (NUTX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
Nutex Health was named a 2026 Houston Top Workplace by the Houston Chronicle, emphasizing their employee engagement and satisfaction.
Key Retail Themes:
employee engagement
top workplace award
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:18 PM ET
Data refreshes hourly during market hours. Next update: 8:18 PM
Data refreshes hourly during market hours. Next update: 8:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NUTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
23 analysts |
$306 | 50 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 34 SELL |
|
CON
Concentra Group Holdings… |
STRONG BUY
11 analysts |
$44 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$156 | 36 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive NUTX Research Pages
